- Home
- UHAL vs EXEL Comparison
UHAL vs EXEL Comparison
Compare UHAL & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UHAL
- EXEL
- Stock Information
- Founded
- UHAL 1945
- EXEL 1994
- Country
- UHAL United States
- EXEL United States
- Employees
- UHAL N/A
- EXEL N/A
- Industry
- UHAL Rental/Leasing Companies
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UHAL Consumer Discretionary
- EXEL Health Care
- Exchange
- UHAL Nasdaq
- EXEL Nasdaq
- Market Cap
- UHAL 12.0B
- EXEL 12.0B
- IPO Year
- UHAL N/A
- EXEL 2000
- Fundamental
- Price
- UHAL $62.31
- EXEL $44.47
- Analyst Decision
- UHAL
- EXEL Buy
- Analyst Count
- UHAL 0
- EXEL 18
- Target Price
- UHAL N/A
- EXEL $44.24
- AVG Volume (30 Days)
- UHAL 182.9K
- EXEL 3.6M
- Earning Date
- UHAL 08-06-2025
- EXEL 07-28-2025
- Dividend Yield
- UHAL N/A
- EXEL N/A
- EPS Growth
- UHAL N/A
- EXEL 237.58
- EPS
- UHAL 1.87
- EXEL 2.20
- Revenue
- UHAL $5,828,665,000.00
- EXEL $2,298,922,000.00
- Revenue This Year
- UHAL $5.55
- EXEL $9.93
- Revenue Next Year
- UHAL $4.94
- EXEL $13.17
- P/E Ratio
- UHAL $33.36
- EXEL $20.18
- Revenue Growth
- UHAL 3.61
- EXEL 24.49
- 52 Week Low
- UHAL $56.28
- EXEL $22.20
- 52 Week High
- UHAL $79.04
- EXEL $49.62
- Technical
- Relative Strength Index (RSI)
- UHAL 52.66
- EXEL 53.42
- Support Level
- UHAL $60.48
- EXEL $44.03
- Resistance Level
- UHAL $62.31
- EXEL $45.52
- Average True Range (ATR)
- UHAL 1.34
- EXEL 1.44
- MACD
- UHAL 0.16
- EXEL -0.06
- Stochastic Oscillator
- UHAL 80.74
- EXEL 22.78
About UHAL U-Haul Holding Company
U-Haul Holding Co is an American moving truck, trailer, and self-storage rental company. The company also provides moving boxes, packing supplies, LPG (propane) refills, trailer hitch and wiring installation, storage container rentals, and other services. It has three reportable segments Moving and Storage, Property and Casualty Insurance, and Life Insurance. The majority of its revenue comes from the Moving and Storage segment.
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.